These tissue changes, caused by repeated injections in the same location, create areas of altered fat distribution that may lead to unpredictable drug uptake
Gradual Uptitration: Patients are closely monitored as the dose is gradually increased in increments of 0.1mg every few weeks, based on individual response and tolerability
Reduced Body Fat Storage: Increasing insulin secretion and reducing glucagon secretion, helps prevent excessive glucose availability for energy, which may decrease body fat storage
Well, although they are popularised by the name GLP-1, these patches actually dont contain GLP-1 agonist drugs
Schedule a personalized consultation today
These characteristics included greater reduction of hemoglobin A1c with treatment, longer duration of diabetes diagnosis and older subject age